(R)-CJ 11974

CAS No. 187281-35-2

(R)-CJ 11974( —— )

Catalog No. M36169 CAS No. 187281-35-2

(R)-CJ 11974 is a novel non-peptide neurokinin NK1 substance P receptor antagonist with potential analgesic activity that can be used to study chemotherapy-induced vomiting.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 409 Get Quote
10MG 604 Get Quote
25MG 908 Get Quote
50MG 1251 Get Quote
100MG 1647 Get Quote
500MG 3312 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (R)-CJ 11974
  • Note
    Research use only, not for human use.
  • Brief Description
    (R)-CJ 11974 is a novel non-peptide neurokinin NK1 substance P receptor antagonist with potential analgesic activity that can be used to study chemotherapy-induced vomiting.
  • Description
    (R)-CJ 11974 is a novel non-peptide neurokinin NK1 substance P receptor antagonist with potential analgesic activity that can be used to study chemotherapy-induced vomiting.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    Neurokinin receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    187281-35-2
  • Formula Weight
    454.65
  • Molecular Formula
    C31H38N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@@H]([C@@H]1[C@H](NCC2=C(OC)C=CC(C(C)C)=C2)C3CCN1CC3)(C4=CC=CC=C4)C5=CC=CC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MLE-4901

    A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia.

  • NIH-12848

    NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) with an IC50 of 1 μM.

  • Aprepitant

    A potent, orally active, long-acting human NK-1 receptor (substance P receptor) antagonist with IC50 of 0.09 nM.